pagoclone has been researched along with Stuttering in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomgren, M; Davis, A; Davis, L; Denko, T; Fox, P; Franklin, D; Maguire, G; Morgenshtern, E; Riley, G; Silverman, A; Soni, P; Spotts, C; Vatakis, NG; Yaruss, JS | 1 |
| Ingham, RJ | 1 |
1 trial(s) available for pagoclone and Stuttering
| Article | Year |
|---|---|
Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the EXamining Pagoclone for peRsistent dEvelopmental Stuttering Study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Partial Agonism; Female; GABA-A Receptor Agonists; Humans; Isoindoles; Male; Middle Aged; Naphthyridines; Pilot Projects; Stuttering; Young Adult | 2010 |
1 other study(ies) available for pagoclone and Stuttering
| Article | Year |
|---|---|
Comments on article by Maguire et al: pagoclone trial: questionable findings for stuttering treatment.
Topics: Child; Clinical Trials as Topic; Humans; Isoindoles; Naphthyridines; Stuttering | 2010 |